Cargando…
Poster: AML-355: Incidence and Severity of COVID-19 among Inpatients with Hematologic Malignancies
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404064/ http://dx.doi.org/10.1016/S2152-2650(21)01368-9 |
_version_ | 1783746092526993408 |
---|---|
author | Wozniaki, Natalia Lacerda, Marcelo Pitombeira Baptista, JoãoPedro Ribeiro Cassi, Helio Vida Neves, Gabriela Duarte Boettcher, Ivan Schneider Dall’Oglio, Ana Claudia Tavares, Fabiana Sanchez Gastal, Gabriela Roncone Luis Schwingel, Fabiano |
author_facet | Wozniaki, Natalia Lacerda, Marcelo Pitombeira Baptista, JoãoPedro Ribeiro Cassi, Helio Vida Neves, Gabriela Duarte Boettcher, Ivan Schneider Dall’Oglio, Ana Claudia Tavares, Fabiana Sanchez Gastal, Gabriela Roncone Luis Schwingel, Fabiano |
author_sort | Wozniaki, Natalia |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8404064 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84040642021-08-30 Poster: AML-355: Incidence and Severity of COVID-19 among Inpatients with Hematologic Malignancies Wozniaki, Natalia Lacerda, Marcelo Pitombeira Baptista, JoãoPedro Ribeiro Cassi, Helio Vida Neves, Gabriela Duarte Boettcher, Ivan Schneider Dall’Oglio, Ana Claudia Tavares, Fabiana Sanchez Gastal, Gabriela Roncone Luis Schwingel, Fabiano Clin Lymphoma Myeloma Leuk Article Elsevier Inc. 2021-09 2021-08-30 /pmc/articles/PMC8404064/ http://dx.doi.org/10.1016/S2152-2650(21)01368-9 Text en Copyright © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Wozniaki, Natalia Lacerda, Marcelo Pitombeira Baptista, JoãoPedro Ribeiro Cassi, Helio Vida Neves, Gabriela Duarte Boettcher, Ivan Schneider Dall’Oglio, Ana Claudia Tavares, Fabiana Sanchez Gastal, Gabriela Roncone Luis Schwingel, Fabiano Poster: AML-355: Incidence and Severity of COVID-19 among Inpatients with Hematologic Malignancies |
title | Poster: AML-355: Incidence and Severity of COVID-19 among Inpatients with Hematologic Malignancies |
title_full | Poster: AML-355: Incidence and Severity of COVID-19 among Inpatients with Hematologic Malignancies |
title_fullStr | Poster: AML-355: Incidence and Severity of COVID-19 among Inpatients with Hematologic Malignancies |
title_full_unstemmed | Poster: AML-355: Incidence and Severity of COVID-19 among Inpatients with Hematologic Malignancies |
title_short | Poster: AML-355: Incidence and Severity of COVID-19 among Inpatients with Hematologic Malignancies |
title_sort | poster: aml-355: incidence and severity of covid-19 among inpatients with hematologic malignancies |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404064/ http://dx.doi.org/10.1016/S2152-2650(21)01368-9 |
work_keys_str_mv | AT wozniakinatalia posteraml355incidenceandseverityofcovid19amonginpatientswithhematologicmalignancies AT lacerdamarcelopitombeira posteraml355incidenceandseverityofcovid19amonginpatientswithhematologicmalignancies AT baptistajoaopedroribeiro posteraml355incidenceandseverityofcovid19amonginpatientswithhematologicmalignancies AT cassiheliovida posteraml355incidenceandseverityofcovid19amonginpatientswithhematologicmalignancies AT nevesgabrieladuarte posteraml355incidenceandseverityofcovid19amonginpatientswithhematologicmalignancies AT boettcherivanschneider posteraml355incidenceandseverityofcovid19amonginpatientswithhematologicmalignancies AT dalloglioanaclaudia posteraml355incidenceandseverityofcovid19amonginpatientswithhematologicmalignancies AT tavaresfabianasanchez posteraml355incidenceandseverityofcovid19amonginpatientswithhematologicmalignancies AT gastalgabrielaroncone posteraml355incidenceandseverityofcovid19amonginpatientswithhematologicmalignancies AT luisschwingelfabiano posteraml355incidenceandseverityofcovid19amonginpatientswithhematologicmalignancies |